FDA Drug Application (078688) for NADOLOL AND BENDROFLUMETHIAZIDE by MYLAN

Back to FDA Applications sponsored by MYLAN

Application Number078688
Product Number001
FormTABLET;ORAL
Dosage5MG;40MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNADOLOL AND BENDROFLUMETHIAZIDE
Active IngredientBENDROFLUMETHIAZIDE; NADOLOL



Back to FDA Applications sponsored by MYLAN

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.